Experimental chemotherapy of Angiostrongylus cantonensis infection in mice with flubendazole, levamisole, and their combination - PubMed (original) (raw)
- PMID: 3583131
Experimental chemotherapy of Angiostrongylus cantonensis infection in mice with flubendazole, levamisole, and their combination
V R Kamath et al. Folia Parasitol (Praha). 1987.
Abstract
The efficacy of the drugs flubendazole, levamisole, and their combination was studied against Angiostrongylus cantonensis infection in mice. The drugs were evaluated on day 15 post infection. The efficacy was assessed by using single-dose and 5-dose treatment schedules. Flubendazole was effective at 25 mg/kg, 50 mg/kg, 100 mg/kg, 200 mg/kg when given each day for five days. Levamisole at a dose rate of 200 mg/kg was completely effective in a single treatment. The combined therapy of levamisole (25 mg/kg) and flubendazole (15 mg/kg) produced 100% efficacy. Both drugs given prior to experimental infection showed no prophylactic activity.
Similar articles
- Chemotherapy and chemoprophylaxis of Angiostrongylus malaysiensis infection in rats with levamisole and mebendazole.
Ambu S, Kwa BH, Mak JW, Singh KI. Ambu S, et al. Folia Parasitol (Praha). 1982;29(4):361-4. Folia Parasitol (Praha). 1982. PMID: 7160790 - In vivo efficacy of levamisole against larval stages of Angiostrongylus cantonensis and A. costaricensis.
Ishii AI, Terada M, Fujiu Y, Sano M. Ishii AI, et al. Southeast Asian J Trop Med Public Health. 1989 Mar;20(1):109-17. Southeast Asian J Trop Med Public Health. 1989. PMID: 2772696 - Levamisole in infectious diseases--a review of the literature.
Brugmans J. Brugmans J. J Rheumatol Suppl. 1978;4:115-21. J Rheumatol Suppl. 1978. PMID: 104036 Review. - Anthelmintic Flubendazole and Its Potential Use in Anticancer Therapy.
Čáňová K, Rozkydalová L, Rudolf E. Čáňová K, et al. Acta Medica (Hradec Kralove). 2017;60(1):5-11. doi: 10.14712/18059694.2017.44. Epub 2017 Apr 11. Acta Medica (Hradec Kralove). 2017. PMID: 28399389 Review.
Cited by
- Management of Rat Lungworm Disease (Neuroangiostrongyliasis) Using Anthelmintics: Recent Updates and Recommendations.
Jacob J, Steel A, Howe K, Jarvi S. Jacob J, et al. Pathogens. 2022 Dec 23;12(1):23. doi: 10.3390/pathogens12010023. Pathogens. 2022. PMID: 36678371 Free PMC article. - Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies.
Jacob J, Steel A, Lin Z, Berger F, Zöeller K, Jarvi S. Jacob J, et al. Clin Infect Dis. 2022 Apr 9;74(7):1293-1302. doi: 10.1093/cid/ciab730. Clin Infect Dis. 2022. PMID: 34448480 Free PMC article. Review. - Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.
Murphy GS, Johnson S. Murphy GS, et al. Hawaii J Med Public Health. 2013 Jun;72(6 Suppl 2):35-40. Hawaii J Med Public Health. 2013. PMID: 23901382 Free PMC article. Review. - Twenty two cases of canine neural angiostrongylosis in eastern Australia (2002-2005) and a review of the literature.
Lunn JA, Lee R, Smaller J, MacKay BM, King T, Hunt GB, Martin P, Krockenberger MB, Spielman D, Malik R. Lunn JA, et al. Parasit Vectors. 2012 Apr 5;5:70. doi: 10.1186/1756-3305-5-70. Parasit Vectors. 2012. PMID: 22480148 Free PMC article. Review.